Jones Trading Downgrades Regulus Therapeutics (RGLS) to Hold
Tweet Send to a Friend
Jones Trading analyst Catherine Novack downgraded Regulus Therapeutics (NASDAQ: RGLS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
